NORGES BANK - REGENXBIO INC ownership

REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 64 filers reported holding REGENXBIO INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
NORGES BANK ownership history of REGENXBIO INC
ValueSharesWeighting
Q4 2022$7,407,696
-14.2%
326,6180.0%0.00%0.0%
Q3 2022$8,632,514
+7.0%
326,6180.0%0.00%0.0%
Q2 2022$8,067,465
-30.2%
326,618
-6.2%
0.00%
-33.3%
Q1 2022$11,562,699
+1.5%
348,3790.0%0.00%
+50.0%
Q4 2021$11,392,000
-15.2%
348,379
+8.7%
0.00%
-33.3%
Q3 2021$13,437,000
+10.3%
320,530
+2.2%
0.00%0.0%
Q2 2021$12,182,000
+5.3%
313,563
-7.5%
0.00%0.0%
Q1 2021$11,568,000
-23.8%
339,135
+1.3%
0.00%
-25.0%
Q4 2020$15,189,000
+67.8%
334,857
+1.8%
0.00%
+100.0%
Q3 2020$9,050,000
-30.9%
328,865
-7.5%
0.00%
-50.0%
Q2 2020$13,089,000
+8.6%
355,378
-4.5%
0.00%0.0%
Q1 2020$12,055,000
-21.0%
372,3100.0%0.00%0.0%
Q4 2019$15,254,000
+15.1%
372,3100.0%0.00%0.0%
Q3 2019$13,254,000
-23.0%
372,310
+11.0%
0.00%
-20.0%
Q2 2019$17,222,000
-5.0%
335,269
+6.0%
0.01%
-16.7%
Q1 2019$18,134,000
+67.9%
316,423
+22.9%
0.01%
+50.0%
Q4 2018$10,798,000
-34.3%
257,399
+18.3%
0.00%
-20.0%
Q3 2018$16,434,000
+1870.5%
217,664
+384.3%
0.01%
Q4 2016$834,000
+796.8%
44,943
+287.5%
0.00%
Q2 2016$93,000
-52.8%
11,597
-36.3%
0.00%
Q1 2016$197,000
-40.7%
18,200
-9.0%
0.00%
Q4 2015$332,000
-24.7%
20,0000.0%0.00%
Q3 2015$441,00020,0000.00%
Other shareholders
REGENXBIO INC shareholders Q1 2016
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 831,014$15,714,4756.51%
MPM BioImpact LLC 617,671$11,680,1593.03%
Sonic GP LLC 193,079$3,651,1242.79%
ArchPoint Investors 224,278$4,241,0971.84%
Redmile Group, LLC 1,640,725$31,026,1101.35%
MIRABELLA FINANCIAL SERVICES LLP 25,983$5,461,3440.83%
WS MANAGEMENT LLLP 396,997$7,507,2130.79%
Redwood Wealth Management Group, LLC 15,190$287,2430.33%
SummerHaven Investment Management, LLC 27,503$520,0820.30%
Lombard Odier Asset Management (Switzerland) SA 130,369$2,465,2780.22%
View complete list of REGENXBIO INC shareholders